+91-8668442535
Home / Biotechnology / Tuberculos

Tuberculosis Diagnostics Market By Test Type (Radiographic Methods, Laboratory Methods, Nucleic Acid Testing, Phage Assay, Cytokine Detection Test, Detection Of Drug Resistance, Mantoux Test) - Growth, Future Prospects, And Competitive Analysis, 2017 -2025

This report on the global tuberculosis diagnostics market studies various tuberculosis diagnostic test types. WHO and the Centers for Disease Control and Prevention (CDC) are leading efforts to raise global awareness of tuberculosis and improve diagnostic methods. The large patient pool suffering from tuberculosis, rising public awareness regarding tuberculosis and early diagnosis, and technological advancement in the testing methods, such as the Mantoux test and the cytokine detection test, are the driving factors for the tuberculosis diagnostics market.

For the purpose of this study, the various types of tuberculosis diagnostic tests studied include radiography methods, laboratory methods, nucleic acid testing, phage assays, cytokine detection tests, detection of drug resistance, and the Mantoux test. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.The global tuberculosis diagnostics market is segmented geographically into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa markets. Market size estimates and forecasts for these segments are provided in US$ Mn, along with the respective CAGRs for the period 2017-2025, using 2016 as the base year.

This report also includes qualitative assessment factors such as market dynamics (drivers, restraints, and opportunities) to have a good understanding of the current and anticipated trends in the global tuberculosis diagnostics market. Competition assessment tools such as market attractiveness assessment and competitive landscape analysis by key players are also demonstrated in the study. Furthermore, this report concludes with a profile of key market players currently enjoying prominent positions in the global tuberculosis diagnostics market. The key players profiled in this report are Abbott Laboratories, Alere Inc., Becton Dickinson and Company, bioMérieux SA, Cepheid Inc., Epistem plc, F. Hoffmann-La Roche Ltd., Hain Lifescience GmbH, Hologic Corporation, Thermo Fisher Scientific, Inc., and Qiagen.

Based on test type, the global tuberculosis diagnostics market is categorized into:

  • Radiographic Methods
  • Laboratory Methods
  • Smear Microscopy
  • culture-based test
  • Nucleic acid testing
  • Phage Assay
  • Cytokine Detection Test
  • Detection of Drug Resistance
  • Mantoux Test

Tuberculosis is one of the leading causes of death worldwide. According to the World Health Organization, in 2013, around 9 million new cases of tuberculosis were reported, with approximately 1.5 million deaths. The tuberculosis diagnostic market segment is driven by factors such as the increasing diagnosis rate in the high prevalence regions, advanced technologies such as radiographic methods and cytokine detection tests, the demand for cost-efficient diagnostic tests, and the launching of technologically advanced diagnostic kits. In 2016, laboratory diagnostics held the largest market share in the test type segment, primarily due to factors such as the rising prevalence of tuberculosis and the fact that they are affordable and very easy to perform.

The limitations of laboratory diagnostic tests, as well as the lengthy incubation period required for diagnosis interpretation, reduce their accuracy. Nucleic acid testing and Mantoux testing will be the fastest growing markets throughout the forecast period of 2017–2025 due to key market drivers such as advanced techniques, a shorter incubation period required for the interpretation of the diagnosis performed, and high accuracy. The major players involved in the manufacturing of the diagnostic kits and equipment are Alere, Inc., Abbott Laboratories, Inc., Thermo Fisher Scientific Inc., Becton Dickinson and Company, F. Hoffmann-La Roche AG, Qiagen, BioMerieux SA, Cephied, Inc., Epistem plc., Hain Lifescience GmbH, and Hologic Corporation.

For the purpose of this study, the global tuberculosis diagnostics market is categorized into three segments:

  • North America
  • U.S.
  • Canada
  • Europe
  • U.K.
  • Germany
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • rest of Latin America
  • Middle East and Africa
  • GCC
  • Rest of the Middle East and Africa

North America will be the fastest-growing market for tuberculosis diagnostics throughout the forecast period of 2017–2025. According to the Centers for Disease Control and Prevention, approximately 9,557 new cases of TB were reported in 2015; the market growth is mainly attributed to rising public awareness of tuberculosis leading to early diagnosis, an evolved reimbursement scenario, and developed healthcare infrastructure. According to the World Health Organization (WHO), in 2015, 323,000 new TB cases were reported in Europe, i.e., approximately 900 people suffered from TB each day. Europe is expected to be the second-largest market due to the rising prevalence of MDR-TB, government and non-government organization grants to strengthen R&D facilities to launch novel tuberculosis diagnostic testing kits and supportive regulatory approval for the tuberculosis diagnostics market.

In the base year 2016, Asia Pacific was observed as the leading market for tuberculosis diagnostics due to factors such as the rising prevalence of tuberculosis (according to the World Health Organization, in South East Asia, annually 2 million people are diagnosed with TB), a competitive market due to manufacturers involved in tuberculosis diagnostic kit production, increasing disposable income in these regions, and government and non-government initiatives to mitigate tuberculosis as per TB programs. However, factors such as developing health infrastructure and increasing awareness about tuberculosis diagnostics are going to fuel the rapid growth of the tuberculosis diagnostics market in Latin America, the Middle East, and Africa in the near future.

Frequently Asked Questions:

The market for Tuberculosis Diagnostics Market is expected to reach US$ 3,326.9 Mn By 2025.

The Tuberculosis Diagnostics Market is expected to see significant CAGR growth over the coming years, at 4.5%.

The report is forecasted from 2015-2025.

The base year of this report is 2014.

Abbott Laboratories, Alere Inc., Becton Dickinson and Company, bioMérieux SA, Cepheid Inc., Epistem plc, F. Hoffmann-La Roche Ltd., Hain Lifescience GmbH, Hologic Corporation, Thermo Fisher Scientific, Inc. are some of the major players in the global market.

Choose License Type
Trusted By
Godaddy
Published Date:  Jul 2017
Category:  Biotechnology
Report ID:   58571
Report Format:   PDF
Pages:   120
Rating:    4.5 (70)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
+91-8668442535
24/7 Research Support